A soluble epoxide hydrolase inhibitor-8-HUDE increases pulmonary vasoconstriction through inhibition of K ATP channels

Yun Liu, Jing Zhang, Lei Yu, Fangyuan Cao, Jingjing Rao, Jing Li, Chun Jiang, J R Falck, Elizabeth R. Jacobs, Daling Zhu

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Epoxyeicosatrienoic acids (EETs), cytochrome P450-derived metabolites of arachidonic acid, are endogenously produced epoxides that act as substrates for the soluble epoxide hydrolase (sEH). Recent studies indicate that EETs increase the tension of rat pulmonary arteries (PAs), and inhibition of sEH augments hypoxic pulmonary vasoconstriction. However, the mechanisms underlying the proconstrictive effects of sEH inhibitors in pulmonary artery smooth muscle cells (PASMCs) are unclear. In the present study, we used a sEH inhibitor, 12-(3-hexylureido) dodec-8-enoic acid (8-HUDE), to examine the ionic mechanisms underlying the constriction of PAs. 8-HUDE increased the tension of rat PAs to 145% baseline in a manner which was effectively eliminated by 10μmol/L glibenclamide, an inhibitor of ATP-sensitive K + (K ATP) channels. Whole cell currents of HEK cells transfected with Kir6.1 or SUR2B were activated by K ATP channel opener pinacidil, inhibited by K ATP channel inhibitor glibenclamide or inhibited by 8-HUDE in a concentration-dependent manner with an IC50 value of 40uM. In addition, 8-HUDE inhibited the expression of Kir6.1 and SUR2B at both mRNA and protein level in rat PASMCs. These observations suggest that 8-HUDE exerts acute effects on K ATP channel activity as well as subacute effects through decreased channel expression, and these effects are, at least in part, via the Kir6.1/SUR2B channel.

Original languageEnglish (US)
Pages (from-to)69-76
Number of pages8
JournalPulmonary Pharmacology and Therapeutics
Volume25
Issue number1
DOIs
StatePublished - Feb 2012

Fingerprint

Epoxide Hydrolases
Vasoconstriction
Pulmonary Artery
Adenosine Triphosphate
Lung
Rats
Glyburide
Smooth Muscle Myocytes
Muscle
Pinacidil
Acids
Epoxy Compounds
Metabolites
Arachidonic Acid
Constriction
Cytochrome P-450 Enzyme System
Inhibitory Concentration 50
Cells
Messenger RNA
Substrates

Keywords

  • 12-(3-hexylureido)dodec-8-enoic acid
  • 8-HUDE
  • ATP-sensitive K (K ) channels
  • Epoxyeicosatrienoic acids (EETs)
  • Pulmonary arteries

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Pharmacology (medical)
  • Biochemistry, medical

Cite this

A soluble epoxide hydrolase inhibitor-8-HUDE increases pulmonary vasoconstriction through inhibition of K ATP channels. / Liu, Yun; Zhang, Jing; Yu, Lei; Cao, Fangyuan; Rao, Jingjing; Li, Jing; Jiang, Chun; Falck, J R; Jacobs, Elizabeth R.; Zhu, Daling.

In: Pulmonary Pharmacology and Therapeutics, Vol. 25, No. 1, 02.2012, p. 69-76.

Research output: Contribution to journalArticle

Liu, Yun ; Zhang, Jing ; Yu, Lei ; Cao, Fangyuan ; Rao, Jingjing ; Li, Jing ; Jiang, Chun ; Falck, J R ; Jacobs, Elizabeth R. ; Zhu, Daling. / A soluble epoxide hydrolase inhibitor-8-HUDE increases pulmonary vasoconstriction through inhibition of K ATP channels. In: Pulmonary Pharmacology and Therapeutics. 2012 ; Vol. 25, No. 1. pp. 69-76.
@article{cc7bd492fbf64711be31e1d847681006,
title = "A soluble epoxide hydrolase inhibitor-8-HUDE increases pulmonary vasoconstriction through inhibition of K ATP channels",
abstract = "Epoxyeicosatrienoic acids (EETs), cytochrome P450-derived metabolites of arachidonic acid, are endogenously produced epoxides that act as substrates for the soluble epoxide hydrolase (sEH). Recent studies indicate that EETs increase the tension of rat pulmonary arteries (PAs), and inhibition of sEH augments hypoxic pulmonary vasoconstriction. However, the mechanisms underlying the proconstrictive effects of sEH inhibitors in pulmonary artery smooth muscle cells (PASMCs) are unclear. In the present study, we used a sEH inhibitor, 12-(3-hexylureido) dodec-8-enoic acid (8-HUDE), to examine the ionic mechanisms underlying the constriction of PAs. 8-HUDE increased the tension of rat PAs to 145{\%} baseline in a manner which was effectively eliminated by 10μmol/L glibenclamide, an inhibitor of ATP-sensitive K + (K ATP) channels. Whole cell currents of HEK cells transfected with Kir6.1 or SUR2B were activated by K ATP channel opener pinacidil, inhibited by K ATP channel inhibitor glibenclamide or inhibited by 8-HUDE in a concentration-dependent manner with an IC50 value of 40uM. In addition, 8-HUDE inhibited the expression of Kir6.1 and SUR2B at both mRNA and protein level in rat PASMCs. These observations suggest that 8-HUDE exerts acute effects on K ATP channel activity as well as subacute effects through decreased channel expression, and these effects are, at least in part, via the Kir6.1/SUR2B channel.",
keywords = "12-(3-hexylureido)dodec-8-enoic acid, 8-HUDE, ATP-sensitive K (K ) channels, Epoxyeicosatrienoic acids (EETs), Pulmonary arteries",
author = "Yun Liu and Jing Zhang and Lei Yu and Fangyuan Cao and Jingjing Rao and Jing Li and Chun Jiang and Falck, {J R} and Jacobs, {Elizabeth R.} and Daling Zhu",
year = "2012",
month = "2",
doi = "10.1016/j.pupt.2011.11.005",
language = "English (US)",
volume = "25",
pages = "69--76",
journal = "Pulmonary Pharmacology and Therapeutics",
issn = "1094-5539",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - A soluble epoxide hydrolase inhibitor-8-HUDE increases pulmonary vasoconstriction through inhibition of K ATP channels

AU - Liu, Yun

AU - Zhang, Jing

AU - Yu, Lei

AU - Cao, Fangyuan

AU - Rao, Jingjing

AU - Li, Jing

AU - Jiang, Chun

AU - Falck, J R

AU - Jacobs, Elizabeth R.

AU - Zhu, Daling

PY - 2012/2

Y1 - 2012/2

N2 - Epoxyeicosatrienoic acids (EETs), cytochrome P450-derived metabolites of arachidonic acid, are endogenously produced epoxides that act as substrates for the soluble epoxide hydrolase (sEH). Recent studies indicate that EETs increase the tension of rat pulmonary arteries (PAs), and inhibition of sEH augments hypoxic pulmonary vasoconstriction. However, the mechanisms underlying the proconstrictive effects of sEH inhibitors in pulmonary artery smooth muscle cells (PASMCs) are unclear. In the present study, we used a sEH inhibitor, 12-(3-hexylureido) dodec-8-enoic acid (8-HUDE), to examine the ionic mechanisms underlying the constriction of PAs. 8-HUDE increased the tension of rat PAs to 145% baseline in a manner which was effectively eliminated by 10μmol/L glibenclamide, an inhibitor of ATP-sensitive K + (K ATP) channels. Whole cell currents of HEK cells transfected with Kir6.1 or SUR2B were activated by K ATP channel opener pinacidil, inhibited by K ATP channel inhibitor glibenclamide or inhibited by 8-HUDE in a concentration-dependent manner with an IC50 value of 40uM. In addition, 8-HUDE inhibited the expression of Kir6.1 and SUR2B at both mRNA and protein level in rat PASMCs. These observations suggest that 8-HUDE exerts acute effects on K ATP channel activity as well as subacute effects through decreased channel expression, and these effects are, at least in part, via the Kir6.1/SUR2B channel.

AB - Epoxyeicosatrienoic acids (EETs), cytochrome P450-derived metabolites of arachidonic acid, are endogenously produced epoxides that act as substrates for the soluble epoxide hydrolase (sEH). Recent studies indicate that EETs increase the tension of rat pulmonary arteries (PAs), and inhibition of sEH augments hypoxic pulmonary vasoconstriction. However, the mechanisms underlying the proconstrictive effects of sEH inhibitors in pulmonary artery smooth muscle cells (PASMCs) are unclear. In the present study, we used a sEH inhibitor, 12-(3-hexylureido) dodec-8-enoic acid (8-HUDE), to examine the ionic mechanisms underlying the constriction of PAs. 8-HUDE increased the tension of rat PAs to 145% baseline in a manner which was effectively eliminated by 10μmol/L glibenclamide, an inhibitor of ATP-sensitive K + (K ATP) channels. Whole cell currents of HEK cells transfected with Kir6.1 or SUR2B were activated by K ATP channel opener pinacidil, inhibited by K ATP channel inhibitor glibenclamide or inhibited by 8-HUDE in a concentration-dependent manner with an IC50 value of 40uM. In addition, 8-HUDE inhibited the expression of Kir6.1 and SUR2B at both mRNA and protein level in rat PASMCs. These observations suggest that 8-HUDE exerts acute effects on K ATP channel activity as well as subacute effects through decreased channel expression, and these effects are, at least in part, via the Kir6.1/SUR2B channel.

KW - 12-(3-hexylureido)dodec-8-enoic acid

KW - 8-HUDE

KW - ATP-sensitive K (K ) channels

KW - Epoxyeicosatrienoic acids (EETs)

KW - Pulmonary arteries

UR - http://www.scopus.com/inward/record.url?scp=84856780301&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84856780301&partnerID=8YFLogxK

U2 - 10.1016/j.pupt.2011.11.005

DO - 10.1016/j.pupt.2011.11.005

M3 - Article

C2 - 22155000

AN - SCOPUS:84856780301

VL - 25

SP - 69

EP - 76

JO - Pulmonary Pharmacology and Therapeutics

JF - Pulmonary Pharmacology and Therapeutics

SN - 1094-5539

IS - 1

ER -